TABLE 2.
Susceptibility testing of 25 C. albicans clinical isolatesa
| Strain or isolate no. | Lab no. | Site of isolation | % Susceptibleb | Interpretation of disk test | 5-FC MIC (mg/liter)c | Interpretation of 5-FC MIC |
|---|---|---|---|---|---|---|
| Reference | F/10089 | Tracheal aspirate | 92 | S | 0.12 | S |
| 1 | F/10101 | Blood | 88 | S | 0.06 | S |
| 2 | F/10141 | Blood | 88 | S | 0.06 | S |
| 3 | F/10084 | BAL | 91 | S | 0.12 | S |
| 4 | F/10155 | Wound | 84 | S | 0.12 | S |
| 5 | F/7421 | Tracheal aspirate | 0 | R | 0.5 | S |
| 6 | F/7822 | Tracheal aspirate | 0 | R | 0.5 | S |
| 7 | F/6633 | Sputum | 0 | R | 1 | S |
| 8 | F/8894 | BAL | 0 | R | 1 | S |
| 9 | F/9732 | Sputum | 0 | R | 1 | S |
| 10 | F/8750 | BAL | 0 | R | 2 | I |
| 11 | F/9651 | Tracheal aspirate | 0 | R | 4 | I |
| 12 | F/9464 | Urine | 0 | R | 8 | I |
| 13 | F/9406 | Mouth | 0 | R | 16 | R |
| 14 | F/6524 | Catheter tip | 0 | R | >64 | R |
| 15 | F/6563 | BAL | 0 | R | >64 | R |
| 16 | F/6698 | Gastric fluid | 0 | R | >64 | R |
| 17 | F/6997 | Urine | 0 | R | >64 | R |
| 18 | F/7451 | Tracheal aspirate | 0 | R | >64 | R |
| 19 | F/7901 | Vaginal swab | 0 | R | >64 | R |
| 20 | F/8082 | Sputum | 0 | R | >64 | R |
| 21 | F/8166 | Sputum | 0 | R | >64 | R |
| 22 | F/8341 | Surgical wound | 0 | R | >64 | R |
| 23 | F/8556 | CSF | 0 | R | >64 | R |
| 24 | F/9161 | Urine | 0 | R | >64 | R |
| Control | C. krusei ATCC 6258 | 2 | I |
a
BAL, bronchoalveolar lavage; CSF, cerebrospinal fluid; S, sensitive; I, intermediate; R, resistant.
b
According to the 5-FC disk method. The percentage value indicates the percent inhibition relative to the control.
c
MIC data determined from colonies around the zone of inhibition on a yeast nitrogen base plate.